Roche Holding Ltd.
ROG
Real-time BATS EUROPE - 09/24 12:07:50 pm
233.525CHF
-0.77%
Prev.235.1500
Open235.0000
High235.5000
Low232.9500
Volume4 042 096
Financials
Sales 2018 56 475 M
EBIT 2018 19 233 M
R. net 2018 12 946 M
Debt 2018 4 708 M
Rend. 2018 3,74%
P/E ratio 2018 15,54
P/E ratio 2019 15,24
EV / Sales 2018 3,67x
EV / Sales 2019 3,52x
Capitalization 203 B
Company
Roche Holding AG operates as a research healthcare company.It operates through the following segments: Diagnostics and Pharmaceuticals.The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.The...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-09-24 Presentation
Trading Rating :
Investor Rating :
Latest news
09/21AbbVie Gets Positive CHMP Opinion for Combination of Venclyxto With Rituximab to Treat Leukemia
DJ
09/13Roche Works to Fill Sales Gap as Biosimilars Emerge -Reuters
DJ
09/13Roche steps up efficiency drive to take sting out of biosimilars
RE
09/13ROCHE : FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
BU
09/13ROCHE : boss says Brexit and curbs on drug use pose threat to UK science
RE
09/10U.K. Health Regulator Rejects Roche's MS Drug
DJ
09/10ROCHE : faces UK pricing row over multiple sclerosis drug Ocrevus
RE
09/06FDA Extends Review Period for Roche Cancer Treatment License
DJ
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishNeutral
Resistance240246252
Spread/Res.-2,6%-5,1%-7,5%
Spread/Supp.-0,77%4,5%12%
Support235223208